Centre for Disability Research, Faculty of Health & Medicine, Lancaster University, UK; Centre for Disability Research & Policy, Faculty of Medicine and Health, University of Sydney, NSW, Australia; College of Nursing and Health Sciences, Flinders University, Adelaide, South Australia, Australia.
Division of Psychiatry, University College London, UK; Centre for Educational Development, Appraisal and Research, University of Warwick, UK; Centre for Developmental Psychiatry and Psychology, Monash University, Australia.
Public Health. 2021 Nov;200:106-108. doi: 10.1016/j.puhe.2021.09.019. Epub 2021 Oct 27.
To estimate levels of COVID-19 vaccine hesitancy among working-age adults with disabilities in the United Kingdom.
Cross-sectional survey.
Secondary analysis of data collected on a nationally representative sample of 10,114 respondents aged 16-64 years.
The adjusted relative risk for hesitancy among respondents with a disability was 0.92 (95% CI 0.67-1.27). There were stronger associations between gender and hesitancy and ethnic status and hesitancy among participants with a disability. The most common reasons cited by people with disabilities who were hesitant were: concern about the future effects of the vaccine, not trusting vaccines and concern about the side effects of vaccination.
The higher rates of vaccine hesitancy among women with disabilities and among people from minority ethnic groups with disabilities are concerning.
评估英国工作年龄段残疾成年人对 COVID-19 疫苗的犹豫程度。
横断面调查。
对全国代表性的 10114 名 16-64 岁受访者进行数据分析。
残疾受访者中犹豫的调整相对风险为 0.92(95%CI 0.67-1.27)。残疾参与者中,性别和犹豫之间以及族裔地位和犹豫之间存在更强的关联。犹豫的残疾人士最常提到的原因是:担心疫苗的未来影响、不信任疫苗以及担心接种疫苗的副作用。
残疾女性和残疾少数族裔群体中更高的疫苗犹豫率令人担忧。